Cell Biotech Co., Ltd. (KOSDAQ:049960)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,790
+70 (0.60%)
At close: Oct 28, 2025
0.60%
Market Cap80.76B
Revenue (ttm)47.46B
Net Income (ttm)10.11B
Shares Out6.84M
EPS (ttm)1,477.23
PE Ratio7.99
Forward PEn/a
Dividend450.00 (3.83%)
Ex-Dividend DateDec 27, 2024
Volume21,386
Average Volume14,605
Open11,780
Previous Close11,720
Day's Range11,670 - 11,900
52-Week Range11,590 - 14,790
Beta0.59
RSI28.22
Earnings DateNov 12, 2025

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1995
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 049960
Full Company Profile

Financial Performance

In 2024, Cell Biotech's revenue was 49.91 billion, a decrease of -7.20% compared to the previous year's 53.79 billion. Earnings were 15.13 billion, an increase of 139.96%.

Financial Statements

News

There is no news available yet.